3,4-dihydroxyphenylacetaldehyde has been researched along with 4-aminobenzoic acid in 1 studies
Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (4-aminobenzoic acid) | Trials (4-aminobenzoic acid) | Recent Studies (post-2010) (4-aminobenzoic acid) |
---|---|---|---|---|---|
99 | 0 | 50 | 2,698 | 55 | 302 |
99 | 0 | 50 | 1,134 | 60 | 322 |
Protein | Taxonomy | 3,4-dihydroxyphenylacetaldehyde (IC50) | 4-aminobenzoic acid (IC50) |
---|---|---|---|
Polyphenol oxidase 2 | Agaricus bisporus | 3.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, AM; Burke, WJ; Conway, AD; Jain, JC; Kristal, BS; Li, SW; Ulluci, PA | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and 4-aminobenzoic acid
Article | Year |
---|---|
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Aminobenzoic Acid; Aminobenzoates; Animals; Aristolochic Acids; Cell Death; Cell Differentiation; Cyclosporine; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; Ion Channels; Male; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nerve Growth Factor; para-Aminobenzoates; Parkinson Disease; PC12 Cells; Phenanthrenes; Rats; Rats, Inbred F344; Respiration; Rotenone; Trifluoperazine; Uncoupling Agents | 2001 |